WallStreetZenWallStreetZen

NASDAQ: LIPO
Lipella Pharmaceuticals Inc Stock Ownership - Who owns Lipella Pharmaceuticals?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Lipella Pharmaceuticals Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Jonathan H. KaufmanDirector2024-03-1925,000$0.87
$21.80kBuy
Jonathan H. KaufmanDirector2024-03-1830,000$0.79
$23.64kBuy
Michael B. ChancellorChief Medical Officer2024-03-13144,906$0.69
$99.99kBuy
Jonathan H. KaufmanDirector2024-03-13144,906$0.69
$99.99kBuy

1 of 1

LIPO insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LIPO insiders and whales buy or sell their stock.

LIPO Shareholders

What type of owners hold Lipella Pharmaceuticals Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Jonathan H. Kaufman14.22%888,849$631.97kInsider
Michael B. Chancellor14.04%877,637$624.00kInsider
Sabby Management LLC4.32%269,829$191.85kInstitution
Geode Capital Management LLC0.67%42,090$29.93kInstitution
Vanguard Group Inc0.55%34,520$24.54kInstitution
Two Sigma Investments LP0.25%15,865$11.28kInstitution
Tower Research Capital LLC Trc0.11%6,919$4.92kInstitution
Ubs Group Ag0.01%761$541.07Institution
Wells Fargo Company0.00%29$20.62Institution
Concourse Financial Group Securities Inc0.00%0$0.00Institution

1 of 1

LIPO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LIPO5.92%28.26%Net BuyingNet Buying
CING0.05%99.95%Net BuyingNet Buying
LGVN14.25%85.75%Net BuyingNet Buying
SNGX0.36%99.64%
THAR1.16%37.18%Net Buying
View Top Biotech Stocks

Lipella Pharmaceuticals Stock Ownership FAQ

Who owns Lipella Pharmaceuticals?

Lipella Pharmaceuticals (NASDAQ: LIPO) is owned by 5.92% institutional shareholders, 28.26% Lipella Pharmaceuticals insiders, and 65.82% retail investors. Jonathan H. Kaufman is the largest individual Lipella Pharmaceuticals shareholder, owning 888,849.00 shares representing 14.22% of the company. Jonathan H. Kaufman's Lipella Pharmaceuticals shares are currently valued at $631.97k.

If you're new to stock investing, here's how to buy Lipella Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.